WNK2 and breast carcinoma: The ErbB receptors themselves regulate estrogen-signaling pathways, either by directly phosphorylating the estrogen receptor, or by activating mitogen-activated protein kinases, which in turn enhance estrogen receptor signaling [13,14]; furthermore, previous studies of breast cancer cell lines have implicated growth factor in signaling repression of PR expression [15].